Recent Finacing
Recent Raise
Congruence Therapeutics is a clinical-stage, computationally driven biotechnology company developing small-molecule correctors using its proprietary Revenir platform.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
See the team members at Congruence Therapeutics.
